BNT162b2 mRNA COVID-19 Vaccine to Fight COVID
Journal: International Journal of Science and Research (IJSR) (Vol.11, No. 2)Publication Date: 2022-02-05
Authors : Vaishna Das K. S.;
Page : 889-889
Keywords : BNT162b2; Safety and efficacy; COVID-19 vaccine;
Abstract
In this article they worked on the safety and efficacy of BNT162b2 mRNA COVID-19 vaccine. This is an mRNA vaccine which codes for SARS-COVID-2 spike protein. The main objective of their study was to have a check on the safety of the vaccine as well as to find out how far it is effective to prevent COVID-19 spread.
Other Latest Articles
- Giant Fibroma during Pregnancy: A Case Report
- Bilateral Adnexal Torsion in the First Trimester of Pregnancy: Case Report
- A Comparative Study of The Pharmacotherapeutic Effects of Capsicum and Zanthoxylum spp: A Systematic Review from Usage as Spice to Potential Clinical Use in Drug Development
- Smart Farming Based on IoT: Nepal Perspective
- Rumor Detection Using Machine Learning in Social Media: A Survey
Last modified: 2022-05-14 21:00:31